Abstract:Background Schistosomiasis japonica remains an important public health concern due to its potential to cause severe outcomes and long-term sequelae. An integrated control strategy implemented in the Peoples’ Republic of China has been shown to be effective to control or interrupt the transmission of schistosomiasis. The objective of this study is to estimate the disease burden of schistosomiasis and assess the cost-effectiveness of the integrated control strategy focused on different major interventions at three stages for schistosomiasis control in a lake setting, to provide reference for policy making or planning. Methods Annual cost data of schistosomiasis control during 2009–2019 were obtained from the control program implementers in Jiangling County, Hubei Province, China. Economic costs are provided in constant 2009 Chinese Yuan (CNY). Epidemiological data of schistosomiasis were collected from the Jiangling county station for schistosomiasis control. Disease burden of schistosomiasis was assessed by calculating years of life lost (YLLs) owing to premature death, years lived with disability (YLDs) and disability-adjusted life years (DALYs). DALYs were calculated as the sum of YLLs and YLDs. We then conducted a rudimentary cost-effectiveness analysis by determining the ratio by dividing the difference between the average cost of integrated control strategy at transmission control (2013–2016) or transmission interruption (2017–2019) and the average cost at stage of infection control (2009–2012) with the difference between the DALYs of schistosomiasis at different control stages. Descriptive statistics on the costs and DALYs were used in the analysis. Results The total economic costs for schistosomiasis control in Jiangling County from 2009 to 2019 were approximately CNY 606.88 million. The average annual economic costs for schistosomiasis prevention and control at stages of infection control (2009–2012), transmission control (2013–2016), and transmission interruption (2017–2019) were approximately CNY 41.98 million, CNY 90.19 million and CNY 26.06 million respectively. The overall disease burden caused by schistosomiasis presented a downward trend. Meanwhile, the disease burden of advanced cases showed an upward trend with the DALY increased from 943.72 to 1031.59 person-years. Most disease burden occurred in the age group over 45 years old (especially the elderly over 60 years old). Taking the infection control stage as the control, the incremental cost-effectiveness ratio of integrated control strategy was CNY 8505.5 per case averted, CNY 60 131.6 per DALY decreased at transmission control stage and CNY −2217.6 per case averted, CNY −18 116.0 per DALY decreased at transmission interruption stage. Conclusions The disease burden of schistosomiasis decreased significantly with the implementation of the integrated prevention and control strategy. Surveillance and management on elder population should be strengthened to decrease diseases burden. There remains a need for well-conducted studies that examine the long-term cost-effectiveness of the integrated control strategy for schistosomiasis. Graphic Abstarct

[Burden of Disease in Schistosomiasis Japonica. I. Calculation and Evaluation of Years Lived with Disability of Chronic Schistosomiasis].

Assessment of the Age-Specific Disability Weight of Chronic Schistosomiasis Japonica/evaluation Du Poids Dans L'incapacite Par Age De La Schistosomiase Sino-Japonaise Chronique/evaluacion Del Peso De La Discapacidad Por Edades Por Esquistosomiasis Japonica Cronica

Burden of disease in Schistosomiasis japonica. IV. Community socioeconomic determinants of chronic schistosomiasis]

Quantifying quality of life and disability of patients with advanced schistosomiasis japonica

Assessment of the age-specific disability weight of chronic schistosomiasis japonica.

[Burden of disease in schistosomiasis japonica III household socioeconomic determinants of chronic schistosomiasis]

Assessing the morbidities of 3405 seropositive residents of schistosome-specific antibodies from schistosomiasis endemic areas in lake regions

Morbidity in Schistosomiasis Japonica in Relation to Intensity of Infection

Burden of schistosomiasis in global, regional, and national 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019

Schistosomiasis in Humans, 1990-2041: Findings from the Global Burden of Disease 2021 Study and Predictions by Bayesian Age-Period-Cohort Analysis

Cost-effectiveness Analysis of the Integrated Control Strategy for Schistosomiasis Japonica in a Lake Region of China: a Case Study

Global trends of schistosomiasis burden from 1990 to 2021 across 204 countries and territories: Findings from GBD 2021 Study

A Study and Analysis of the Deaths Due to Advanced Schistosoma Japonicum Infection in the Dongting Lake Area of China.

Cost-effectiveness Analysis of the Integrated Control Strategy for Schistosomiasis Japonica in Lake Region of China: a Jiangling Case Study

Assessment of the Effect of Treatment and Assistance Program on Advanced Patients with Schistosomiasis Japonica in China from 2009 to 2014.

A Multivariate Analysis of the Relationship Between Work Ability and S. Japonicum Infection in Dongting Lake Region, in China

Impact of historical disease conditions on mortality and life expectancy in patients with advanced schistosomiasis in Hunan Province, China

[A Case-Control Study on Risk Factors for Advanced Schistosomiasis Japonica].

Evaluation of the Disease Burden of Sporadic Creutzfeldt-Jacob Disease with the Surveillance Data from 2013 to 2017 in China

Life expectancy and healthy life expectancy of patients with advanced schistosomiasis in Hunan Province, China

The morbidity investigation of residents in a highly endemic village of schistosomiasis in Poyang Lake region]